SmartTRAK reports from SAWC Spring in Charlotte, NC, and finds a market rebuilding following a significant reimbursement shift.
The US Advanced Wound Care (AWC) Market reached a record in 2025, over three times the size of the market in 2022. This unprecedented growth, primarily driven by the use of high-priced skin substitutes in the post-acute sector, has disrupted the existing market and the leading players within it. This disruption was reflected in the exhibit hall at the 2026 Symposium on Advanced Wound Care (SAWC) Spring meeting, with many of the most imposing stands belonging to companies that were not present in previous iterations.
SmartTRAK spoke with leading figures from a range of companies, and it is clear that there is a desire to proactively shape the future of the US Market. A consistent theme of discussions was that companies expect to see significant merger and acquisition activity in 2026. In this downloadable article, SmartTRAK focuses on the technologies that may be most likely to be involved in transactions this year, as well as some that may be lined up for the future, including:
-
Antimicrobials and Dressings - The US Antimicrobials Market has grown at a 5-year CAGR of +7.6%, and although silver growth has been slightly below that rate, it still accounts for over three-quarters of the total market. There are a number of new technologies coming to the US Market in the coming years ... (read more)
-
Wound Biologics - With the price cap of ~$127 cm² significantly reducing the value of the Skin Substitute Market through PFS, many companies have focused on ... (read more)
-
Devices and Diagnostics - The growth of negative pressure wound therapy (NPWT) is anticipated to slow in the coming years. There are, however, a number of devices with unique or combination modes of action entering the wound device space. Several companies have filed patents around a combination NPWT and oxygen therapy product, and ... (read more)
SmartTRAK believes that wound imaging with fluorescence is on the precipice of gaining wider usage and adoption. Several factors point to the potential future growth, including: the increased need for wound size documentation; additional companies playing in this space; and the upcoming potentially positive changes in reimbursement. In this article, SmartTRAK also discusses the current reimbursement situation and the upcoming changes, and looks at the growth in fluorescence over the past two years ...
From CMS reimbursement disruption to emerging wound imaging and biologics technologies, this article uncovers the trends and companies poised to influence the future of wound care. Click the button below to download the full article and see how leading companies are positioning themselves to influence the next generation of wound care solutions.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s proprietary methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
